• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

清肠温中汤通过抑制 M1 巨噬细胞极化缓解 DSS 诱导的炎症性肠病。

Qingchang Wenzhong Decoction Alleviates DSS-Induced Inflammatory Bowel Disease by Inhibiting M1 Macrophage Polarization and .

机构信息

Graduate School, Beijing University of Chinese Medicine, Beijing, China.

Department of Gastroenterology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.

出版信息

Biomed Res Int. 2022 Aug 25;2022:9427076. doi: 10.1155/2022/9427076. eCollection 2022.

DOI:10.1155/2022/9427076
PMID:36060126
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9436576/
Abstract

BACKGROUND

An imbalance of macrophage M1/M2 polarization significantly influences the pathogenesis of inflammatory bowel disease. Qingchang Wenzhong decoction (QCWZD) has a proven therapeutic effect on patients with inflammatory bowel disease (IBD) and can significantly inhibit the inflammatory response in mice with colitis. However, its effect on macrophages during IBD treatment remains nebulous. . Explore the mechanism underlying QCWZD effects in a dextran sulfate sodium (DSS)-induced colitis mouse model in vivo and RAW264.7 cell in vitro by observing macrophage polarization dynamics.

METHODS

The main active components of QCWZD were determined using high-performance liquid chromatography. Surface marker expression on M1-type macrophages was analyzed using flow cytometry and immunofluorescence. The effect on inducible nitric oxide synthase (iNOS), interleukin-6 (IL-6), and tumor necrosis factor- (TNF-) released by M1 type macrophages was determined using ELSA and RT-PCR. The expression of key proteins in the JAK2/STAT3 signaling pathway was analyzed using western blotting. QCWZD cytotoxicity in macrophages was measured using CCK8 and Annexin V-FITC/PI assays.

RESULTS

The main active components of QCWZD were berberine chloride, coptisine chloride, epiberberine chloride, gallic acid, ginsenoside Rg1, ginsenoside Rb1, indigo, indirubin, notoginsenoside R1, palmatine chloride, and 6-curcumin. QCWZD markedly alleviated DSS-induced colitis in mice, as revealed by the rescued weight loss and disease activity index, attenuated the colonic shortening and mucosal injury associated with the inhibition of M1 macrophage polarization and expression of related cytokines, such as IL-6 and TNF-, and . Furthermore, QCWZD decreased the iNOS, JAK2, and STAT3 levels and , regulating the JAK2/STAT3 signaling pathway.

CONCLUSION

QCWZD administration improves intestinal inflammation by inhibiting M1 macrophage polarization. The JAK2/STAT3 signaling pathway may mediate the effects of QCWZD on M1 macrophage polarization in colitis treatment. This study presents a novel macrophage-mediated therapeutic strategy for the treatment of IBD.

摘要

背景

巨噬细胞 M1/M2 极化失衡显著影响炎症性肠病的发病机制。清肠温中汤(QCWZD)对炎症性肠病(IBD)患者有明确的治疗作用,可显著抑制结肠炎小鼠的炎症反应。但其在 IBD 治疗中对巨噬细胞的作用仍不清楚。本研究通过观察巨噬细胞极化动态,探讨 QCWZD 在葡聚糖硫酸钠(DSS)诱导的结肠炎小鼠模型体内和 RAW264.7 细胞体外的作用机制。

方法

采用高效液相色谱法测定 QCWZD 的主要活性成分。采用流式细胞术和免疫荧光法分析 M1 型巨噬细胞表面标志物的表达。采用 ELISA 和 RT-PCR 测定 M1 型巨噬细胞诱导型一氧化氮合酶(iNOS)、白细胞介素-6(IL-6)和肿瘤坏死因子-(TNF-)的释放。采用 Western blot 分析 JAK2/STAT3 信号通路关键蛋白的表达。采用 CCK8 和 Annexin V-FITC/PI 检测 QCWZD 对巨噬细胞的细胞毒性。

结果

QCWZD 的主要活性成分为盐酸小檗碱、盐酸黄连碱、盐酸巴马汀、没食子酸、人参皂苷 Rg1、人参皂苷 Rb1、靛蓝、靛玉红、三七皂苷 R1、盐酸巴马汀和 6-姜黄素。QCWZD 明显缓解 DSS 诱导的小鼠结肠炎,表现为体重减轻和疾病活动指数得到挽救,结肠缩短和黏膜损伤减轻,同时抑制 M1 巨噬细胞极化和相关细胞因子如 IL-6 和 TNF-的表达。此外,QCWZD 降低了 iNOS、JAK2 和 STAT3 水平,并调节 JAK2/STAT3 信号通路。

结论

QCWZD 给药通过抑制 M1 巨噬细胞极化改善肠道炎症。JAK2/STAT3 信号通路可能介导 QCWZD 对结肠炎治疗中 M1 巨噬细胞极化的作用。本研究为 IBD 治疗提供了一种新的巨噬细胞介导的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/53b44431a39e/BMRI2022-9427076.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/72cb8bf5c988/BMRI2022-9427076.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/9e264311b74f/BMRI2022-9427076.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/345798b2b9fe/BMRI2022-9427076.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/997d80c4a68a/BMRI2022-9427076.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/6cba52c02a91/BMRI2022-9427076.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/e55bb552f8a2/BMRI2022-9427076.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/53b44431a39e/BMRI2022-9427076.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/72cb8bf5c988/BMRI2022-9427076.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/9e264311b74f/BMRI2022-9427076.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/345798b2b9fe/BMRI2022-9427076.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/997d80c4a68a/BMRI2022-9427076.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/6cba52c02a91/BMRI2022-9427076.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/e55bb552f8a2/BMRI2022-9427076.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/9436576/53b44431a39e/BMRI2022-9427076.007.jpg

相似文献

1
Qingchang Wenzhong Decoction Alleviates DSS-Induced Inflammatory Bowel Disease by Inhibiting M1 Macrophage Polarization and .清肠温中汤通过抑制 M1 巨噬细胞极化缓解 DSS 诱导的炎症性肠病。
Biomed Res Int. 2022 Aug 25;2022:9427076. doi: 10.1155/2022/9427076. eCollection 2022.
2
Combining Metagenomics, Network Pharmacology and RNA-Seq Strategies to Reveal the Therapeutic Effects and Mechanisms of Qingchang Wenzhong Decoction on Inflammatory Bowel Disease in Mice.运用宏基因组学、网络药理学和 RNA-Seq 策略揭示清肠温中汤治疗小鼠炎症性肠病的疗效及作用机制。
Drug Des Devel Ther. 2024 Sep 24;18:4273-4289. doi: 10.2147/DDDT.S473688. eCollection 2024.
3
Qingchang Wenzhong Decoction reduce ulcerative colitis in mice by inhibiting Th17 lymphocyte differentiation.清肠温中汤通过抑制 Th17 淋巴细胞分化减轻溃疡性结肠炎小鼠的病情。
Phytomedicine. 2022 Dec;107:154460. doi: 10.1016/j.phymed.2022.154460. Epub 2022 Sep 16.
4
Qingchang Wenzhong Decoction ameliorates intestinal inflammation and intestinal barrier dysfunction in ulcerative colitis via the GC-C signaling pathway.清肠温中汤通过 GC-C 信号通路改善溃疡性结肠炎的肠道炎症和肠屏障功能障碍。
J Ethnopharmacol. 2024 Mar 25;322:117503. doi: 10.1016/j.jep.2023.117503. Epub 2023 Dec 1.
5
Ginsenoside Rg1 ameliorated experimental colitis by regulating the balance of M1/M2 macrophage polarization and the homeostasis of intestinal flora.人参皂苷 Rg1 通过调节 M1/M2 巨噬细胞极化平衡和肠道菌群稳态改善实验性结肠炎。
Eur J Pharmacol. 2022 Feb 15;917:174742. doi: 10.1016/j.ejphar.2022.174742. Epub 2022 Jan 6.
6
Qingchang Wenzhong Decoction Accelerates Intestinal Mucosal Healing Through Modulation of Dysregulated Gut Microbiome, Intestinal Barrier and Immune Responses in Mice.清肠温中汤通过调节小鼠肠道微生物群失调、肠道屏障和免疫反应促进肠道黏膜愈合。
Front Pharmacol. 2021 Sep 7;12:738152. doi: 10.3389/fphar.2021.738152. eCollection 2021.
7
An investigation into the HIF-dependent intestinal barrier protective mechanism of Qingchang Wenzhong decoction in ulcerative colitis management.探讨清肠温中汤在溃疡性结肠炎治疗中通过 HIF 依赖的肠道屏障保护机制。
J Ethnopharmacol. 2024 May 10;325:117807. doi: 10.1016/j.jep.2024.117807. Epub 2024 Jan 26.
8
Protective Effect of Qingchang Wenzhong Decoction on Colitis and Colitis-Related Carcinogenesis by Regulating Inflammation and Intestinal Fibrosis.清肠温中汤通过调节炎症和肠道纤维化对结肠炎及结肠炎相关癌变的保护作用
J Inflamm Res. 2023 Apr 7;16:1479-1495. doi: 10.2147/JIR.S402395. eCollection 2023.
9
Jiedu Xiaozheng Yin Inhibits the Progression of Colitis Associated Colorectal Cancer by Stimulating Macrophage Polarization Towards an M1 Phenotype via the TLR4 Pathway.解毒消癥饮通过 TLR4 通路刺激巨噬细胞向 M1 表型极化抑制结肠炎相关结直肠癌的进展。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241247061. doi: 10.1177/15347354241247061.
10
The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.五环三萜羽扇豆醇可将M1巨噬细胞转变为M2巨噬细胞,并改善实验性炎症性肠病。
Int Immunopharmacol. 2016 Jan;30:74-84. doi: 10.1016/j.intimp.2015.11.031. Epub 2015 Dec 3.

引用本文的文献

1
Huaiyu pill alleviates inflammatory bowel disease in mice blocking toll like receptor 4/ myeloid differentiation primary response gene 88/ nuclear factor kappa B subunit 1 pathway.怀玉丸通过阻断 Toll 样受体 4/髓样分化初级反应基因 88/核因子 kappa B 亚基 1 通路缓解小鼠炎症性肠病。
J Tradit Chin Med. 2024 Oct;44(5):916-925. doi: 10.19852/j.cnki.jtcm.20240719.001.
2
Atox1 regulates macrophage polarization in intestinal inflammation via ROS-NLRP3 inflammasome pathway.Atox1 通过 ROS-NLRP3 炎性小体通路调节肠道炎症中的巨噬细胞极化。
J Transl Med. 2024 May 25;22(1):497. doi: 10.1186/s12967-024-05314-4.
3
Retracted: Qingchang Wenzhong Decoction Alleviates DSS-Induced Inflammatory Bowel Disease by Inhibiting M1 Macrophage Polarization and .

本文引用的文献

1
A Dietary Cholesterol-Based Intestinal Inflammation Assay for Improving Drug-Discovery on Inflammatory Bowel Diseases.一种基于膳食胆固醇的肠道炎症检测方法,用于改善炎症性肠病的药物发现。
Front Cell Dev Biol. 2021 Jun 3;9:674749. doi: 10.3389/fcell.2021.674749. eCollection 2021.
2
Macrophage polarization in intestinal inflammation and gut homeostasis.肠道炎症和肠道稳态中的巨噬细胞极化。
Inflamm Res. 2020 Dec;69(12):1163-1172. doi: 10.1007/s00011-020-01398-y. Epub 2020 Sep 4.
3
Ginsenoside Rd therapy improves histological and functional recovery in a rat model of inflammatory bowel disease.
撤回:清肠温中汤通过抑制M1巨噬细胞极化减轻右旋糖酐硫酸钠诱导的炎症性肠病及…… (原文此处不完整)
Biomed Res Int. 2023 Dec 29;2023:9813901. doi: 10.1155/2023/9813901. eCollection 2023.
4
Exosome-mediated macrophage regulation for inflammatory bowel disease repair: a potential target of gut inflammation.外泌体介导的巨噬细胞调节促进炎症性肠病修复:肠道炎症的一个潜在靶点。
Am J Transl Res. 2023 Dec 15;15(12):6970-6987. eCollection 2023.
5
Repairing the intestinal mucosal barrier of traditional Chinese medicine for ulcerative colitis: a review.中药修复溃疡性结肠炎肠黏膜屏障的研究进展
Front Pharmacol. 2023 Oct 24;14:1273407. doi: 10.3389/fphar.2023.1273407. eCollection 2023.
人参皂苷 Rd 治疗可改善炎症性肠病大鼠模型的组织学和功能恢复。
Phytother Res. 2020 Nov;34(11):3019-3028. doi: 10.1002/ptr.6734. Epub 2020 May 28.
4
Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota.青黛通过改变肠道微生物群减轻葡聚糖硫酸钠诱导的大鼠结肠炎。
Front Microbiol. 2020 Apr 30;11:731. doi: 10.3389/fmicb.2020.00731. eCollection 2020.
5
Heme protects intestinal mucosal barrier in DSS-induced colitis through regulating macrophage polarization in both HO-1-dependent and HO-1-independent way.血红素通过 HO-1 依赖和非依赖两种方式调节巨噬细胞极化来保护 DSS 诱导结肠炎中的肠道黏膜屏障。
FASEB J. 2020 Jun;34(6):8028-8043. doi: 10.1096/fj.202000313RR. Epub 2020 Apr 17.
6
Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.基于微生物和针对微生物的疗法治疗炎症性肠病。
Dig Dis Sci. 2020 Mar;65(3):757-788. doi: 10.1007/s10620-020-06090-z.
7
Ulcerative Colitis: Current and Emerging Treatment Strategies.溃疡性结肠炎:当前及新出现的治疗策略
J Clin Med. 2019 Dec 30;9(1):94. doi: 10.3390/jcm9010094.
8
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD.肠道炎症和消退中的巨噬细胞:IBD 的潜在治疗靶点。
Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):531-543. doi: 10.1038/s41575-019-0172-4. Epub 2019 Jul 16.
9
Gut Microbiota-Mediated NLRP12 Expression Drives the Attenuation of Dextran Sulphate Sodium-Induced Ulcerative Colitis by Qingchang Wenzhong Decoction.肠道微生物群介导的NLRP12表达通过清肠温中汤减轻葡聚糖硫酸钠诱导的溃疡性结肠炎。
Evid Based Complement Alternat Med. 2019 Apr 2;2019:9839474. doi: 10.1155/2019/9839474. eCollection 2019.
10
Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in microglia.白术内酯 III 通过抑制小胶质细胞中 JAK2/STAT3/Drp1 依赖性线粒体分裂来改善脑缺血损伤和神经炎症。
Phytomedicine. 2019 Jun;59:152922. doi: 10.1016/j.phymed.2019.152922. Epub 2019 Apr 6.